Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of the Effects of Laying Early a Gastric Band on the Prevention of Morbid Obesity Randomized Checked Against Standard Management of Obesity in This Population. (CHADO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01700738
Recruitment Status : Unknown
Verified October 2012 by University Hospital, Angers.
Recruitment status was:  Not yet recruiting
First Posted : October 4, 2012
Last Update Posted : October 4, 2012
Sponsor:
Information provided by (Responsible Party):
University Hospital, Angers

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:

MAIN OBJECTIVE To compare the effects of the placement of an adjustable gastric band with "conventional" treatment of obesity.

SECONDARY OBJECTIVES

  • Compare the effects of the placement of a gastric band with "conventional" treatment of obesity on quality of life, body composition and parameters of the metabolic syndrome.
  • Identify predictors of "good answer to the ring" to determine the best future indications.
  • Study of the gastric tolerance.

INCLUSION CRITERIA

  1. Adolescents 12 to 16 years and with BMI and weight gain according to sex and age is greater than IMCZ-score > 4 DP> 8 kg
  2. Obesity "common" non-syndromic.
  3. Medical decision of surgical placement of laparoscopic gastric banding.
  4. Adolescent and family who understand and accept the need for medical and surgical follow long term.
  5. Adolescent and family who fully understood the oral and written information explaining the study and the need for prolonged follow-up.
  6. Obtention of oral and written consent of the adolescent and the parents.
  7. Parents and adolescents affiliated with the social security system.

NONINCLUSION CRITERIA

  1. Intellectual Deficit.
  2. psychiatrics contraindication of surgical placement of laparoscopic gastric banding.
  3. Obesity with severe binge eating.
  4. Pregnancy or wishes of pregnancy in the following year.
  5. Non accession adolescent and / or family in the process of medical care before inclusion.
  6. Predictable post surgical monitoring difficulties.
  7. Suspicion of physical abuse, verbal or negligence / deficiency in care of the family.
  8. Participation in a clinical study evaluating a treatment during the 2 years of the study.

EXCLUSION CRITERIA

  1. Anesthetic contre indication for placement of a gastric laparoscopic.
  2. IMC> 50 kg/m2 the day of inclusion.

STRATEGIES / PROCEDURES During a routine visit, the study will be presented to the patient and his family. Patients will then be enrolled and randomized. Patients in group A (surgery group) will follow the usual multidisciplinary bariatric surgery in adolescents. Patients in group B start conventional monitoring dietary medical and physical. For both groups follow-up visits will occur every 3 months for 2 years.


Condition or disease Intervention/treatment Phase
Obesity Procedure: gastric ring surgery Other: nutritional help Phase 4

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 200 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Evaluation of the Effects of Laying Early (Between 12 and 16) a Gastric Band on the Prevention of Morbid Obesity in Late Adolescence. Randomized Checked Against Standard Management of Obesity in This Population.
Study Start Date : November 2012
Estimated Primary Completion Date : November 2015
Estimated Study Completion Date : November 2015
Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: gastric ring surgery
in this group a gastric ring will be put by surgery.
 Procedure: gastric ring surgery
Active Comparator: nutritional help
the usual treatment of obesity in France with nutritional care will be dispensed for this arm
 Other: nutritional help


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. BMIZ-score evolution in 2 years. [ Time Frame: 2 years ]

Secondary Outcome Measures :
  1. Evolution of quality of life scales [ Time Frame: 1, 2, 5 and 10 years ]
  2. Evaluation of des alimentary attitudinal troubles and psychiatrical troubles [ Time Frame: 1 year ]
  3. Evolution of BMIZ-score [ Time Frame: 1, 5 and 10 years ]
  4. Evolution of round-waist [ Time Frame: 1, 2, 5 and 10 years ]
  5. Evolution of bodily composition. [ Time Frame: 1, 2, 5 and 10 years ]
  6. Evolution of metabolic syndrome parameters. [ Time Frame: 1, 2, 5 and 10 years ]
  7. Evolution of respiratory parameters: polysomnography [ Time Frame: 2 years ]
  8. Determination of success factors of the ring. [ Time Frame: 2 years ]
  9. Study of tolerance of the gastric ring. [ Time Frame: 1, 2, 5 and 10 years ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   12 Years to 16 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Adolescents 12 to 16 years and with BMI and weight gain according to sex and age is greater than IMCZ-score > 4 DP> 8 kg
  2. Obesity "common" non-syndromic.
  3. Medical decision of surgical placement of laparoscopic gastric banding.
  4. Adolescent and family who understand and accept the need for medical and surgical follow long term.
  5. Adolescent and family who fully understood the oral and written information explaining the study and the need for prolonged follow-up.
  6. Obtention of oral and written consent of the adolescent and the parents.
  7. Parents and adolescents affiliated with the social security system.

EXCLUSION CRITERIA

  1. Intellectual Deficit.
  2. psychiatrics contraindication of surgical placement of laparoscopic gastric banding.
  3. Obesity with severe binge eating.
  4. Pregnancy or wishes of pregnancy in the following year.
  5. Non accession adolescent and / or family in the process of medical care before inclusion.
  6. Predictable post surgical monitoring difficulties.
  7. Suspicion of physical abuse, verbal or negligence / deficiency in care of the family.
  8. Participation in a clinical study evaluating a treatment during the 2 years of the study.
  9. Anesthetic contre indication for placement of a gastric laparoscopic.
  10. IMC> 50 kg/m2 the day of inclusion.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01700738


Contacts
Layout table for location contacts
Contact: REGIS COUTANT recoutant@chu-angers.fr

Locations
Layout table for location information
France
University Hospital of Angers
Angers, France, 49000
Principal Investigator: REGIS COUTANT         
Sub-Investigator: FRANCOISE SCHMITT         
Principal Investigator: GUILLAUME PODEVIN         
Sub-Investigator: JEAN-LOUIS GINIES         
Sub-Investigator: AGNES SALLE         
University Hospital of Caen
Caen, France, 14033
Contact: DOMINIQUE BOUGLE    0231515161      
Principal Investigator: DOMINIQUE BOUGLE         
Sub-Investigator: JULIEN ROD         
Sub-Investigator: MURIEL LAURANS         
Principal Investigator: YANNICK LE ROUX         
Sub-Investigator: MARIE-ASTRID PIQUET         
University hospital Bicêtre
Le Kremlin Bicetre, France, 94275
Contact: PIERRE BOUGNIERES    0145217832      
Principal Investigator: PIERRE BOUGNIERE         
Sub-Investigator: GIANPAOLO DE FILIPPO         
Sub-Investigator: CATHERINE PIQUARD         
University Hospital of Lille
Lille, France, 59037
Contact: IVA GUEORGUIEVA    0320446885      
Principal Investigator: IVA GUEORGUIEVA         
Sub-Investigator: JACQUES WEILL         
Principal Investigator: ESTELLE AUBRY         
Sub-Investigator: FRANCOIS PATTOU         
Sub-Investigator: MARIE PIGEYRE         
University Hospital of Necker
Paris, France, 75743
Contact: OLIVIER GOULET    0144492501      
Principal Investigator: OLIVIER GOULET         
Sub-Investigator: MYRIAM TYAN-DABBAS         
Principal Investigator: NAZIHA KHEN-DUNLOP         
University Hospital of Toulouse
Toulouse, France, 31059
Contact: MAITHE TAUBER    0534558555      
Principal Investigator: MAITHE TAUBER         
Sub-Investigator: GWENAELLE DIENE         
Sub-Investigator: BEATRICE JOURET         
Sub-Investigator: PATRICK RITZ         
Sponsors and Collaborators
University Hospital, Angers
Investigators
Layout table for investigator information
Principal Investigator: REGIS COUTANT UNIVERSITY HOSPITAL OF ANGERS
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Layout table for additonal information
Responsible Party: University Hospital, Angers
ClinicalTrials.gov Identifier: NCT01700738    
Other Study ID Numbers: 2012 - A00555-38
First Posted: October 4, 2012    Key Record Dates
Last Update Posted: October 4, 2012
Last Verified: October 2012
Additional relevant MeSH terms:
Layout table for MeSH terms
Obesity
Obesity, Morbid
Overnutrition
 Nutrition Disorders
Overweight
Body Weight